Showing results (361-370 of 673) with videos related to

Sort By:
Pageof 68
Journal of Neurochemistry|January 5, 2016
Sign-trackers have elevated myo-inositol in the nucleus accumbens and ventral hippocampus following Pavlovian conditioned approachChristopher J Fitzpatrick, Shane A Perrine, Farhad Ghoddoussi, et al.
The American Surgeon|September 1, 1986
A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infectionsM Joshi, B J Fitzpatrick, J W Warren, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 17, 1998
Safety of influenza vaccine in heart transplant recipientsE A Blumberg, J Fitzpatrick, P C Stutman, et al.
Irish Journal of Medical Science|October 28, 2008
Alcohol, drug misuse and suicide attempts: unrecognised causes of out of hospital cardiac arrests admitted to intensive care unitsA M McLaughlin, J Hardt, A P McKay, et al.
The Journal of Nursing Administration|May 18, 2006
Differences in perceptions of empowerment among nationally certified and noncertified nursesIrene M Piazza, Moreen Donahue, Patricia C Dykes, et al.
Cell Reports|December 25, 2012
Human telomeres are tethered to the nuclear envelope during postmitotic nuclear assemblyLaure Crabbe, Anthony J Cesare, James M Kasuboski, et al.
Hematological Oncology|April 1, 1986
The effect of vinblastine on CFU-E in normal and W anaemic miceD S Chervinsky, C Tebbi, D Williams, et al.
Journal of Obesity|April 17, 2014
Predictors of weight loss maintenance following an insurance-sponsored weight management programChristiaan G Abildso, Olivier Schmid, Megan Byrd, et al.
Biomaterials|November 1, 1988
Hydrophilic polyphosphazenes as hydrogels: radiation cross-linking and hydrogel characteristics of poly[bis(methoxyethoxyethoxy)phosphazene]H R Allcock, S Kwon, G H Riding, et al.
European Urology|January 1, 1996
The international terazosin trial: a multicentre study of the long-term efficacy and safety of terazosin in the treatment of benign prostatic hyperplasia. The ITT GroupF M Debruyne, W P Witjes, J Fitzpatrick, et al.
Pageof 68